{"url_path":"/sec/sgmt/8-k/2026-04-27/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1400118/0001104659-26-048971-index.html","accession_number":"0001104659-26-048971","cik":"0001400118","ticker":"SGMT","issuer_name":"Sagimet Biosciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1400118/0001104659-26-048971-index.html","primary_entity_key":"0001400118","primary_entity_name":"Sagimet Biosciences Inc."},"word_count":129,"has_tables":true,"body_markdown":"**Item 7.01**\n**Regulation FD Disclosure.**\n\n \n\nOn April 27, 2026, the Company updated\ninformation reflected in a slide presentation, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated\nherein by reference. Representatives of the Company will use the updated presentation in various meetings with investors from time to\ntime.\n\n \n\nThe information in Item 7.01 of this Current\nReport on Form 8-K, including the information set forth in Exhibit 99.1, is being furnished and shall not be deemed “filed”\nfor purposes of Section 18 of the Exchange Act, nor shall Exhibit 99.1 furnished herewith be deemed incorporated by reference\nin any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."}